Loading insider details...
Beta
Latest Form 4 (Jun 22, 2026): Grant/Award of 989 NPCE shares, $15.5K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 22, 2026 | NeuroPace Inc (NPCE) | Grant/Award | 989 | $15.5K |
| Jun 5, 2026 | NeuroPace Inc (NPCE) | Grant/Award | 2,890 | n/a |
| Mar 23, 2026 | NeuroPace Inc (NPCE) | Grant/Award | 1,153 | $15.0K |
| Dec 23, 2025 | NeuroPace Inc (NPCE) | Grant/Award | 904 | $15.0K |
| Sep 22, 2025 | NeuroPace Inc (NPCE) | Grant/Award | 1,509 | $15.0K |
| Jun 24, 2025 | NeuroPace Inc (NPCE) | Grant/Award | 3,340 | $15.0K |
| Jun 9, 2025 | NeuroPace Inc (NPCE) | Grant/Award | 8,745 | n/a |
| Feb 25, 2025 | Roivant Sciences Ltd. (ROIV) | Tax Withholding | 958 | $10.3K |
| Feb 19, 2025 | Roivant Sciences Ltd. (ROIV) | Exercise/Conversion | 187,500 | $721.9K |
| Jan 23, 2025 | Roivant Sciences Ltd. (ROIV) | Tax Withholding | 1,057 | $11.8K |